PTCHF
Price
$1.82
Change
+$0.03 (+1.68%)
Updated
Aug 27 closing price
Capitalization
435.82M
STTK
Price
$0.99
Change
-$0.00 (-0.00%)
Updated
Aug 29, 04:14 PM (EDT)
Capitalization
47.56M
74 days until earnings call
Interact to see
Advertisement

PTCHF vs STTK

Header iconPTCHF vs STTK Comparison
Open Charts PTCHF vs STTKBanner chart's image
PureTech Health
Price$1.82
Change+$0.03 (+1.68%)
Volume$7.72K
Capitalization435.82M
Shattuck Labs
Price$0.99
Change-$0.00 (-0.00%)
Volume$100
Capitalization47.56M
PTCHF vs STTK Comparison Chart in %
Loading...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTCHF vs. STTK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTCHF is a Buy and STTK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (PTCHF: $1.82 vs. STTK: $0.99)
Brand notoriety: PTCHF and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTCHF: 75% vs. STTK: 4%
Market capitalization -- PTCHF: $435.82M vs. STTK: $47.56M
PTCHF [@Biotechnology] is valued at $435.82M. STTK’s [@Biotechnology] market capitalization is $47.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCHF’s FA Score shows that 0 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • PTCHF’s FA Score: 0 green, 5 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both PTCHF and STTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTCHF’s TA Score shows that 4 TA indicator(s) are bullish while STTK’s TA Score has 4 bullish TA indicator(s).

  • PTCHF’s TA Score: 4 bullish, 3 bearish.
  • STTK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTCHF is a better buy in the short-term than STTK.

Price Growth

PTCHF (@Biotechnology) experienced а +1.68% price change this week, while STTK (@Biotechnology) price change was +10.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

STTK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($436M) has a higher market cap than STTK($47.6M). PTCHF YTD gains are higher at: -9.000 vs. STTK (-17.942). PTCHF has higher annual earnings (EBITDA): -53.65M vs. STTK (-61.22M). PTCHF has more cash in the bank: 502M vs. STTK (50.5M). STTK has less debt than PTCHF: STTK (2.97M) vs PTCHF (24M). STTK has higher revenues than PTCHF: STTK (3M) vs PTCHF (0).
PTCHFSTTKPTCHF / STTK
Capitalization436M47.6M916%
EBITDA-53.65M-61.22M88%
Gain YTD-9.000-17.94250%
P/E Ratio10.71N/A-
Revenue03M-
Total Cash502M50.5M994%
Total Debt24M2.97M808%
FUNDAMENTALS RATINGS
PTCHF: Fundamental Ratings
PTCHF
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTCHFSTTK
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HROW38.990.20
+0.52%
Harrow
FBIN58.94-0.57
-0.96%
Fortune Brands Innovations
TSLA345.98-3.62
-1.04%
Tesla
KUKE1.63-0.04
-2.40%
Kuke Music Holding Limited
SI14.81-0.96
-6.09%
Shoulder Innovations Inc

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and KURA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
KURA - PTCHF
30%
Poorly correlated
+2.67%
PRTC - PTCHF
30%
Poorly correlated
-3.66%
STTK - PTCHF
24%
Poorly correlated
-0.71%
LYEL - PTCHF
23%
Poorly correlated
-1.60%
BCTX - PTCHF
22%
Poorly correlated
-3.95%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-0.71%
ACAD - STTK
39%
Loosely correlated
-1.28%
LSB - STTK
38%
Loosely correlated
+1.25%
VRTX - STTK
36%
Loosely correlated
+0.76%
ADCT - STTK
35%
Loosely correlated
+0.93%
NAUT - STTK
32%
Poorly correlated
-2.21%
More